As a transcriptional factor, HMGA2 is increased in many malignant tumors such as lung cancer 41, ovarian cancer 42, and bladder cancer 43, which targets different downstream genes in the process of tumorigenesis 44, 45, 46. This evidence concerns the gene HMGA2 and ovarian carcinoma.